Classification of Colorectal Cancer in Molecular Subtypes by Immunohistochemistry.
暂无分享,去创建一个
Louis Vermeulen | Anne Trinh | L. Vermeulen | J. D. de Jong | A. Trinh | Sanne Ten Hoorn | Joan de Jong | Lianne Koens | L. Koens | S. ten Hoorn
[1] Andreas Schlicker,et al. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition , 2013, International journal of cancer.
[2] P. Roche,et al. Immunohistochemical Analysis for hMLH1 and hMSH2 Expression in Colorectal Cancer. , 2001, Methods in molecular medicine.
[3] L. Vermeulen,et al. Cancer heterogeneity—a multifaceted view , 2013, EMBO reports.
[4] G. Orphanides,et al. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines , 2012, BMC Medical Genomics.
[5] Florian Markowetz,et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions , 2013, Nature Medicine.
[6] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[7] Lewis C Cantley,et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy , 2013, Nature Medicine.
[8] F. Markowetz,et al. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry , 2016, Clinical Cancer Research.
[9] Mira Ayadi,et al. Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.
[10] K. Halling,et al. Microsatellite instability testing. , 2001, Methods in molecular medicine.
[11] Sabine Tejpar,et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer , 2013, The Journal of pathology.